Protein Corona Inhibits Endosomal Escape of Functionalized DNA Nanostructures in Living Cells

biomedical applications 0301 basic medicine endolysosomal escape Biochemistry therapeutic agents biological response dn biological activity DNA nanotechnology protein corona determines functionalized dns nanotechnology programmable manner study offers cell size increasingly used biological liquids well established linearly dependent Medicine Protein Corona functionalized dna nanostructures living cells Biotechnology Chemical Sciences not elsewhere classified analysis indicates Biophysics 612 Endosomes Inorganic Chemistry important basis 03 medical and health sciences protein corona Cell Line, Tumor Genetics various biomedical applications Humans turn modulates Pharmacology future optimization limited studies endosome escape peptide nanomaterials become covered cellular uptake Cell Biology DNA Nanostructures Nucleic Acid Conformation bionano interactions Adsorption Lysosomes Developmental Biology Antimicrobial Cationic Peptides
DOI: 10.1021/acsami.1c14401 Publication Date: 2021-09-27T22:06:35Z
ABSTRACT
DNA nanostructures (DNs) can be designed in a controlled and programmable manner, and these structures are increasingly used in a variety of biomedical applications, such as the delivery of therapeutic agents. When exposed to biological liquids, most nanomaterials become covered by a protein corona, which in turn modulates their cellular uptake and the biological response they elicit. However, the interplay between living cells and designed DNs are still not well established. Namely, there are very limited studies that assess protein corona impact on DN biological activity. Here, we analyzed the uptake of functionalized DNs in three distinct hepatic cell lines. Our analysis indicates that cellular uptake is linearly dependent on the cell size. Further, we show that the protein corona determines the endolysosomal vesicle escape efficiency of DNs coated with an endosome escape peptide. Our study offers an important basis for future optimization of DNs as delivery systems for various biomedical applications.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (124)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....